| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13481* | 2021 |
| Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland MD Johnson, N Kenney, A Stoica, L Hilakivi-Clarke, B Singh, G Chepko, ... Nature medicine 9 (8), 1081-1084, 2003 | 726 | 2003 |
| Meta-analysis of soy intake and breast cancer risk BJ Trock, L Hilakivi-Clarke, R Clarke Journal of the National Cancer Institute 98 (7), 459-471, 2006 | 703 | 2006 |
| The properties of high-dimensional data spaces: implications for exploring gene and protein expression data R Clarke, HW Ressom, A Wang, J Xuan, MC Liu, EA Gehan, Y Wang Nature reviews cancer 8 (1), 37-49, 2008 | 698 | 2008 |
| Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines EW Thompson, S Paik, N Brünner, CL Sommers, G Zugmaier, R Clarke, ... Journal of cellular physiology 150 (3), 534-544, 1992 | 675 | 1992 |
| Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance BJ Trock, F Leonessa, R Clarke Journal of the National Cancer Institute 89 (13), 917-931, 1997 | 637 | 1997 |
| Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling R Clarke, MC Liu, KB Bouker, Z Gu, RY Lee, Y Zhu, TC Skaar, B Gomez, ... Oncogene 22 (47), 7316-7339, 2003 | 633 | 2003 |
| Cellular and molecular pharmacology of antiestrogen action and resistance R Clarke, F Leonessa, JN Welch, TC Skaar Pharmacological reviews 53 (1), 25-72, 2001 | 532 | 2001 |
| Endocrine resistance in breast cancer–an overview and update R Clarke, JJ Tyson, JM Dixon Molecular and cellular endocrinology 418, 220-234, 2015 | 383 | 2015 |
| ATP binding cassette transporters and drug resistance in breast cancer. F Leonessa, R Clarke Endocrine-related cancer 10 (1), 43-73, 2003 | 348 | 2003 |
| Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer C Thangavel, JL Dean, A Ertel, KE Knudsen, CM Aldaz, AK Witkiewicz, ... Endocrine-related cancer 18 (3), 333-345, 2011 | 341 | 2011 |
| A maternal diet high in n − 6 polyunsaturated fats alters mammary gland development, puberty onset, and breast cancer risk among female rat offspring L Hilakivi-Clarke, R Clarke, I Onojafe, M Raygada, E Cho, M Lippman Proceedings of the National Academy of Sciences 94 (17), 9372-9377, 1997 | 327 | 1997 |
| MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780 N Brünner, TL Frandsen, C Holst-Hansen, M Bei, EW Thompson, ... Cancer research 53 (14), 3229-3232, 1993 | 272 | 1993 |
| Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis L Hilakivi-Clarke, I Onojafe, M Raygada, E Cho, T Skaar, I Russo, ... British journal of cancer 80 (11), 1682-1688, 1999 | 263 | 1999 |
| Endoplasmic reticulum stress, the unfolded protein response, autophagy, and the integrated regulation of breast cancer cell fate R Clarke, KL Cook, R Hu, COB Facey, I Tavassoly, JL Schwartz, ... Cancer research 72 (6), 1321-1331, 2012 | 262 | 2012 |
| Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring. L Hilakivi-Clarke, E Cho, I Onojafe, M Raygada, R Clarke Oncology reports 6 (5), 1089-1184, 1999 | 240 | 1999 |
| Chloroquine inhibits autophagy to potentiate antiestrogen responsiveness in ER+ breast cancer KL Cook, A Wärri, DR Soto-Pantoja, PAG Clarke, MI Cruz, A Zwart, ... Clinical Cancer Research 20 (12), 3222-3232, 2014 | 238 | 2014 |
| MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal … N Brünner, B Boysen, S Jirus, TC Skaar, C Holst-Hansen, J Lippman, ... Cancer research 57 (16), 3486-3493, 1997 | 235 | 1997 |
| Human X‐box binding protein‐1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines BP Gomez, RB Riggins, AN Shajahan, U Klimach, A Wang, AC Crawford, ... The FASEB Journal 21 (14), 4013-4027, 2007 | 226 | 2007 |
| Dynamic modelling of oestrogen signalling and cell fate in breast cancer cells JJ Tyson, WT Baumann, C Chen, A Verdugo, I Tavassoly, Y Wang, ... Nature Reviews Cancer 11 (7), 523-532, 2011 | 220 | 2011 |
Leena Hilakivi-ClarkeGeorgetown University Medical CenterVerified email at georgetown.edu
